Related by context. All words. (Click for frequent words.) 77 B CLL 70 refractory chronic lymphocytic 68 cell malignancies 68 Chronic lymphocytic leukemia CLL 67 leukemia CLL 67 cell acute lymphoblastic 66 refractory cutaneous T 66 ovarian cancer chronic hepatitis 65 Peginterferon alfa 2b 65 myelodysplastic syndromes MDS 65 Cell Non Hodgkin 64 LymphoStat B belimumab 64 leukemia AML 64 myelodysplastic syndrome MDS 64 RAF kinase 64 PNP inhibitor 64 Epratuzumab 64 myelodysplastic syndromes 64 refractory acute promyelocytic 64 cell lymphoma CTCL 64 HuMax CD4 64 Campath ® 63 previously untreated follicular 63 Amgen Neulasta R 63 sodium glucose cotransporter 63 imatinib Gleevec ® 63 cell lymphoma DLBCL 63 formerly LymphoStat B 63 pediatric acute lymphoblastic 63 YONDELIS 63 Clofarabine 63 refractory indolent non 63 registrational trial 63 myelodysplastic myeloproliferative diseases 63 relapsed refractory multiple myeloma 63 Amrubicin 63 precursor acute lymphoblastic 63 relapsed leukemia 63 AVASTIN 63 erlotinib Tarceva ® 63 cutaneous T 63 generation purine nucleoside 63 systemic anaplastic large 63 proteasome inhibitor 63 cell lymphomas 62 Evoltra ® 62 relapsed Acute Myeloid 62 corticosteroid dexamethasone 62 TRISENOX ® 62 follicular Non Hodgkin 62 dasatinib Sprycel ® 62 methylnaltrexone bromide 62 relapsed refractory 62 Xcellerated T Cells 62 Clolar ® 62 plus DOXIL 62 Annamycin 62 refractory acute myeloid 62 ® lenalidomide 62 Letairis ambrisentan 62 small lymphocytic lymphoma 62 dasatinib Sprycel 62 Bezielle 62 non metastatic osteosarcoma 62 relapsed acute myelogenous 62 Acute Myeloid Leukemia AML 62 diarrhea predominant irritable 62 receptor tyrosine kinase inhibitor 62 Onco TCS 62 HBeAg negative chronic hepatitis 62 grade cervical intraepithelial 61 relapsing remitting MS RRMS 61 follicular non 61 Fludara ® 61 RANK Ligand inhibitor 61 advanced metastatic renal 61 bendamustine 61 non Hodgkin lymphomas 61 refractory Hodgkin lymphoma 61 follicular CD# positive 61 romiplostim 61 stage IIIB 61 Rituxan rituximab 61 Cutaneous T 61 Tiuxetan 61 Orphan Drug designations 61 Aplidin 61 tumors GIST 61 Personalized Immunotherapy 61 EOquin 61 refractory multiple myeloma 61 SPRYCEL ® 61 Daclizumab 61 docetaxel Taxotere R 61 Telintra 61 xanthine oxidase inhibitor 61 IMiDs 61 cutaneous T cell 61 Hodgkin lymphoma HL 61 arsenic trioxide injection 61 Navelbine ® 61 Zorbtive TM 61 R bendamustine hydrochloride 61 demethylation agents 61 opioid induced constipation OIC 61 MAGE A3 ASCI 61 leukemia ALL 61 RITUXAN 61 valtorcitabine 61 TREANDA 61 ofatumumab HuMax CD# 61 NF Kappa 60 pegfilgrastim 60 Panzem R 60 Relapsed Refractory 60 humanized monoclonal antibody 60 sorafenib tablets 60 Ceflatonin 60 mRCC 60 nucleoside analog 60 CCR5 receptor antagonist 60 HQK 60 Leukine ® 60 Gleevec imatinib mesylate 60 fluoropyrimidine 60 relapsed multiple myeloma 60 nucleoside analogue 60 Vidaza azacitidine 60 Kit CD# positive 60 cell lymphoma ALCL 60 Campath 60 five MDS subtypes 60 Ibritumomab Tiuxetan 60 Troxatyl 60 indolent follicular non 60 hepatocellular carcinoma HCC 60 Plicera 60 R Saizen R 60 RhuDex ® 60 CLL SLL 60 HER2 positive metastatic breast 60 grade cervical dysplasia 60 regulate NF kappa 60 novel histone deacetylase 60 Genentech Rituxan 60 unresectable recurrent 60 Hodgkin lymphoma NHL 60 posaconazole 60 denileukin diftitox 60 non splenectomized 60 CVP chemotherapy 60 TYGACIL 60 targeted radiotherapeutic 60 KNS # 60 refractory peripheral T 60 hypereosinophilic syndrome 60 PEGylated interferon beta 1a 60 unresectable 60 TNF Tumor Necrosis Factor 60 Ixempra 60 histone deacetylase HDAC inhibitor 60 Pemetrexed 60 docetaxel Taxotere ® 60 Vidofludimus 60 Vidaza R 60 chronic lymphocytic leukemia CLL 60 Fodosine 60 LymphoStat B TM 59 cirrhotic CHC monoinfected patients 59 cetuximab Erbitux R 59 relapsed MM 59 Omacetaxine 59 Lenalidomide 59 lymphoma CTCL 59 Philadelphia Chromosome Positive 59 BAY #-# 59 imatinib mesylate 59 TYZEKA 59 secondary hyperparathyroidism 59 Arsenic trioxide 59 cell carcinoma RCC 59 Alemtuzumab 59 thymalfasin 59 CTAP# Capsules 59 patients receiving myelosuppressive 59 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 59 metastatic malignant 59 CHOP chemotherapy 59 advanced hepatocellular carcinoma 59 MabCampath 59 mertansine 59 octreotide acetate 59 recurrent NSCLC 59 COPEGUS R 59 Velcade bortezomib 59 Follicular lymphoma 59 hormone LHRH antagonist 59 cancer neuroendocrine tumor 59 PEGINTRON TM 59 Archexin 59 Granulocyte Colony Stimulating Factor 59 cirrhosis liver failure 59 oral ridaforolimus 59 metastatic colorectal 59 oropharyngeal candidiasis OPC 59 Xeloda ® 59 IMiD 59 R lenalidomide 59 sunitinib Sutent ® 59 VIDAZA 59 Cloretazine 59 micafungin 59 grade glioma 59 Actimmune ® 59 beta 1a 59 CD# monoclonal antibody 59 hormone refractory prostate cancer 59 lumiliximab 59 dirucotide MBP# 59 dirucotide 59 antibody MAb 59 brand ciclesonide HFA 59 Lubiprostone 59 Clolar 59 IgG1 monoclonal antibody 59 liposomal formulation 59 Mitoxantrone 59 forodesine 59 chronic idiopathic thrombocytopenic purpura 59 PEGylated anti 59 metastatic bladder 59 INTEGRILIN R eptifibatide Injection 59 PDX pralatrexate 59 ADP receptor antagonist 59 unresectable hepatocellular carcinoma HCC 59 thalidomide Thalomid 59 Xanafide 59 multiple myeloma MM 59 elacytarabine 59 pegylated interferons 59 oral prodrug 59 luteinizing hormone releasing 59 mTOR inhibitor 59 refractory gout 59 alpha folate receptor 59 diagnosed Ph + 59 leukemia APL 59 clofarabine 59 5alpha reductase 59 unresectable locally advanced 59 CYT# potent vascular disrupting 59 induced macular edema 59 Vandetanib 59 metastatic carcinoma 59 smoldering multiple myeloma 59 Tarceva TM 59 Fludarabine 59 pancreatic enzyme replacement 59 recombinant interferon 58 plus prednisone prednisolone 58 BENLYSTA TM 58 ZEVALIN ® 58 valopicitabine 58 BCG refractory carcinoma 58 calcineurin inhibitors 58 hematological malignancies 58 KRAS wild 58 B lymphocyte stimulator 58 Voreloxin 58 Alferon N Injection 58 metaglidasen 58 Ph + acute lymphoblastic 58 highly selective endothelin 58 indolent NHL 58 Arranon 58 radiation sensitizer 58 Somatuline R Depot 58 non metastatic resectable 58 Copegus ribavirin 58 castrate resistant prostate cancer 58 refractory NSCLC 58 R bisoprolol Euthyrox 58 alvespimycin 58 Zolinza 58 metastatic renal cell carcinoma 58 myelofibrosis polycythemia vera 58 lenalidomide Revlimid R 58 Chronic Lymphocytic Leukemia 58 Nexavar sorafenib 58 everolimus tablets 58 virus HCV protease inhibitor 58 HBeAg positive chronic hepatitis 58 stage IIIb IV 58 gemcitabine cisplatin 58 Elacytarabine 58 RhuDex TM 58 Pegloticase 58 Ribavirin causes 58 HBeAg negative 58 Leukemia AML 58 MT# MEDI 58 hepatitis C HCV 58 etanercept Enbrel 58 Azacitidine 58 gemcitabine carboplatin 58 relapsed mantle 58 metastatic hormone refractory 58 EGFR expressing mCRC 58 ara C 58 Vicinium TM 58 Increlex R 58 Taxotere docetaxel 58 HCD# [002] 58 gastrointestinal stromal tumor GIST 58 Insegia 58 Imatinib mesylate 58 Aflibercept 58 myeloproliferative diseases 58 Mepact 58 Irinotecan 58 vapreotide acetate 58 RoACTEMRA 58 non nucleoside inhibitor 58 Azedra 58 sargramostim 58 syndrome IBS 58 Tyzeka 58 depsipeptide 58 Ganciclovir 58 Gel repository corticotropin injection 58 Increlex ® 58 Firazyr 58 Phase #b/#a clinical 58 Dasatinib 58 BCG refractory 58 PI3K/Akt pathway inhibitor 58 refractory metastatic colorectal cancer 58 Campath alemtuzumab 58 A1PI 58 Dabigatran etexilate 58 hereditary deficiency 58 TRISENOX 58 Mimpara 58 Ozarelix 58 Increlex TM 58 galiximab 58 Fludara 58 Certolizumab pegol 58 AEG# 58 HRPC 58 Tasigna nilotinib 58 acute GvHD 58 Nexavar tablets 58 R #Y ibritumomab 58 invasive candidiasis 58 Noxafil 58 pediatric Crohn disease 58 dose Ara 58 taxane chemotherapy 58 REVLIMID lenalidomide 58 Specifid 58 gefitinib Iressa 58 PEGylated Fab fragment 58 chronic HBV 58 liposomal amphotericin B 58 Methylnaltrexone 58 advanced metastatic prostate 58 Zavesca R 58 ixabepilone 58 BCR ABL inhibitors 58 Zavesca ® 57 decompensated liver disease 57 DISCUSSION AND POSSIBLE APPROVAL 57 Romiplostim 57 Berinert 57 Albugon 57 monoclonal antibody conjugated 57 protease inhibitor PI 57 acyclovir Lauriad R 57 IMiDs ® 57 Naive Patients 57 Fc fusion protein 57 investigational monoclonal antibody 57 Bosutinib 57 efaproxiral 57 Pralatrexate 57 subependymal giant cell 57 Gleevec Glivec 57 metastatic gastric 57 HBeAg positive 57 2 methoxyestradiol 57 Elagolix 57 Somatuline Depot 57 Camptosar ® 57 acute myelogenous leukemia AML 57 thetreatment 57 alefacept 57 recurrent glioblastoma multiforme 57 FavId 57 Metastatic breast cancer 57 refractory CTCL 57 purpura ITP 57 ibritumomab tiuxetan 57 TMC# [002] 57 alkylating agent 57 Ceflatonin R 57 Pradefovir 57 oral vancomycin 57 idiopathic thrombocytopenic purpura ITP 57 hyperphenylalaninemia HPA due 57 targeted antifolate 57 Raptiva ® 57 Kuvan R 57 virus HCV infection 57 tinidazole 57 Phase III randomized controlled 57 chronic myeloid leukemia CML 57 rheumatoid arthritis RA psoriatic 57 bortezomib Velcade R 57 Dementia Related Psychosis 57 orally administered inhibitor 57 refractory chronic myeloid 57 romidepsin 57 panitumumab Vectibix 57 IMPDH inhibitor 57 Gleevec resistant 57 tiuxetan 57 BARACLUDE ® 57 JAK inhibitor 57 terlipressin 57 Dacogen decitabine 57 MOVIPREP R 57 elotuzumab 57 Sanofi Aventis Taxotere 57 Advanced Renal Cell 57 metastatic GIST 57 gastrointestinal stromal tumors 57 systemic fungal infections 57 Temsirolimus 57 sorafenib Nexavar R 57 relapsed refractory aggressive 57 aerosolized AAT 57 TEMODAL 57 sorafenib Nexavar 57 apaziquone 57 Chronic lymphocytic leukemia 57 hematological cancers 57 essential thrombocythemia ET 57 TheraCIM 57 tumor xenograft models 57 CVP cyclophosphamide vincristine 57 gemtuzumab ozogamicin 57 Piperacillin 57 Canvaxin TM 57 Alzhemed TM 57 relapsing multiple sclerosis 57 TNF antagonist 57 GW# [003] 57 targeting CD# 57 Gleevec imatinib 57 adriamycin 57 chronic myeloid 57 trabectedin 57 ruxolitinib 57 constipation predominant irritable bowel 57 CD3 monoclonal antibody 57 Sudhir Agrawal D.Phil 57 lymphoid malignancies 57 Rituxan MabThera 57 anthracycline containing 57 Zarnestra 57 esophageal candidiasis 57 hepatocellular carcinomas 57 include Healive 57 HuLuc# 57 Cloretazine ® 57 tazobactam 57 polymerase inhibitor 57 TELINTRA 57 Bevacizumab Avastin 57 Diffuse Large B 57 Chronic Myelogenous Leukemia CML 57 Tyrima 57 dopamine partial agonist 57 delta gamma agonist 57 vinorelbine tartrate 57 anthracycline taxane 57 posterior uveitis 57 sunitinib malate 57 vinca alkaloid 57 Zenvia ™ 57 Paraplatin ® 57 invasive fungal infections 57 DOXIL 57 HMG CoA reductase inhibitors 57 Nilotinib 57 personalized immunotherapy 57 rasagiline tablets 57 nonsmall cell lung cancer 57 efalizumab 57 EDEMA3 57 Fibrillex TM 57 herpetic keratitis 57 selective inhibitor 57 tyrosine kinase inhibitor TKI 57 Carboplatin 57 effector function 57 metastatic castrate resistant 57 Raptiva R 57 mecasermin 57 Azilect ® 57 ularitide 57 Herceptin trastuzumab 57 unique alkylating agent 57 octreotide implant 57 INVANZ 57 Interferon beta 57 myeloproliferative disorders 57 Romidepsin 57 ELACYT 57 recurrent colorectal cancer 57 metastatic colorectal carcinoma 57 small molecule Hedgehog 57 Gemzar ® 57 Hycamtin ® 57 Neuvenge 57 reduce serum phosphate 57 Allovectin 7 57 CCR5 antagonist 57 Lymphocytic 57 XL# XL# 57 tamibarotene 57 LEUKINE 57 Blinatumomab 57 peginterferon alfa 2a Pegasys 57 Neulasta R 57 alkylating agents 57 secondary hyperparathyroidism SHPT 57 delivers fluocinolone acetonide FA 57 Arzerra ofatumumab 57 UPLYSO 56 primary humoral immunodeficiency 56 phase IIb clinical 56 reslizumab 56 dextromethorphan quinidine 56 novel VDA molecule 56 metastatic renal 56 stage IIIA 56 BAL# [002] 56 Non Hodgkin 56 chronic ITP patients 56 medullary thyroid cancer 56 hypomethylating agents 56 Zevalin R Ibritumomab 56 CTCL 56 relapsed acute lymphoblastic 56 Phase III VELCADE 56 TRO# 56 TORISEL 56 temsirolimus 56 product Fentanyl TAIFUN 56 PrevOnco 56 superficial bladder cancer 56 investigational immunotherapy 56 BEXXAR 56 Dacogen injection 56 Phase #/#a trial 56 XmAb# 56 selective modulator 56 Perifosine KRX 56 Degarelix 56 AA amyloidosis 56 echinocandin 56 chemotherapeutic agent 56 EOquin TM 56 Marqibo 56 calcineurin inhibitor 56 radiotherapeutic 56 Perifosine 56 dose corticosteroids 56 epothilone 56 cytarabine daunorubicin 56 Loramyc R 56 CDK inhibitor 56 arthritis PsA 56 PRTX 56 Luteinizing Hormone Releasing Hormone 56 MULTAQ 56 PROCRIT 56 Onrigin 56 Genasense ® 56 AAG geldanamycin analog 56 somatostatin analogue 56 Ocrelizumab 56 pediatric malignancies 56 Follicular Lymphoma 56 remission induction 56 Levoleucovorin 56 MYLOTARG 56 ONTAK 56 dose dexamethasone 56 volociximab 56 refractory Hodgkin 56 gastrin analogue TT 56 regorafenib 56 baminercept 56 Omnitarg 56 idarubicin 56 Treanda 56 metastatic pancreatic 56 Gemzar gemcitabine 56 nucleoside naive 56 imatinib Gleevec 56 IL# PE#QQR 56 Gamunex C 56 amrubicin 56 GTC recombinant human 56 CML CP 56 resistant hormone refractory 56 dose escalation clinical 56 TYKERB 56 Argatroban 56 gemcitabine Gemzar ® 56 IV Busulfex 56 histamine dihydrochloride 56 MDS MPD 56 common hematologic malignancy 56 Erlotinib 56 refractory AML 56 refractory PTCL 56 Abacavir 56 Rituximab 56 PROCRIT ® 56 Squamous 56 MyVax R 56 AVONEX ® 56 Glioblastoma multiforme GBM 56 triciribine phosphate monohydrate 56 ZACTIMA 56 Talabostat 56 epithelial tumors 56 post herpetic neuralgia PHN 56 candidemia 56 EGFR TKI 56 Cancidas 56 singer Angela Bofill 56 CD# antigen 56 atypical hemolytic uremic syndrome 56 pralatrexate 56 blinatumomab 56 VELCADE melphalan 56 MyVax ® 56 Trastuzumab 56 infusional 5-FU/LV 56 ALN HPN 56 interferon alfa 56 PSN# [001] 56 SCCHN 56 anti muscarinic 56 boosted protease inhibitor 56 nucleotide analog 56 leukemia CML 56 oropharyngeal candidiasis 56 castration resistant 56 ocrelizumab 56 alpha interferons 56 LHRH agonists 56 Bendamustine 56 immunomodulatory therapy 56 Delafloxacin 56 erlotinib Tarceva 56 pancreatic NET 56 atherothrombotic events 56 bleomycin 56 Sezary syndrome 56 zidovudine AZT 56 porcine derived 56 oral antiviral 56 Safinamide 56 dose melphalan 56 fludarabine phosphate 56 Kepivance 56 grade prostatic intraepithelial 56 acute humoral rejection 56 Mg Uk 56 caspofungin 56 bevacizumab Avastin ® 56 CD8 + cytotoxic 56 Taxotere chemotherapy 56 imatinib resistant 56 Amigal 56 HGS ETR1 56 visilizumab 56 CIMZIA TM 56 MDS AML 56 ganetespib 56 Allovectin 7 ® 56 peritumoral brain edema 56 HGS ETR2 56 Oxaliplatin 56 neutropenia dehydration dyspnea 56 candesartan cilexetil 56 chronic HBV infection 56 non squamous NSCLC 56 dexamethasone Decadron 56 OHR/AVR# 56 REBETOL combination therapy 56 Atypical Hemolytic Uremic Syndrome 56 antiplatelet agent 56 Peginterferon 56 isoenzyme 56 doxorubicin HCl liposome injection 56 histone deacetylase inhibitor 56 biologic therapy 56 lupus nephritis 56 hormone refractory 56 ZOLINZA 56 Torisel 56 deletion 5q 56 brostallicin 56 syngeneic 56 trans retinoic acid ATRA 56 chemotherapy induced neutropenia 56 BrachySil 56 bendamustine HCl 56 carcinoma mCRC 56 evaluating Xcytrin 56 recurrent genital herpes 56 NYHA Class II 56 carcinoid syndrome 56 rilonacept 55 registrational 55 SinuNase TM 55 Laquinimod 55 intranasal formulation 55 sapropterin dihydrochloride Tablets 55 Apoptone 55 e antigen HBeAg 55 DEB# 55 thiazolides 55 receiving INTRON 55 CANCIDAS 55 eltrombopag 55 Avonex interferon beta 1a 55 ATL# [001] 55 vandetanib 55 Myelofibrosis 55 FOLOTYN 55 Hepatocellular Carcinoma HCC 55 plus COPEGUS 55 cytopenias 55 doxercalciferol 55 PegIntron 55 Benlysta belimumab 55 macroglobulinemia 55 tuberous sclerosis TS 55 Tarceva erlotinib 55 urocortin 2 55 Arcalyst 55 pseudobulbar affect PBA 55 Traficet EN 55 castration resistant prostate cancer 55 Etoposide 55 dihydrochloride 55 grade gliomas 55 drug ISA# 55 oral Hycamtin 55 Apolipoprotein B 55 meropenem 55 FOLFOX6 chemotherapy regimen 55 inhaled liposomal ciprofloxacin 55 HCl Tablets 55 mesylate 55 PEG interferon 55 Octreolin 55 trastuzumab Herceptin ® 55 paroxysmal nocturnal hemoglobinuria PNH 55 acute leukemias 55 Leukine 55 Proxinium TM 55 corticotropin injection 55 5-FU/LV 55 lupus renal disease 55 Mylotarg 55 azacytidine 55 DAVANAT 55 refractory acute lymphoblastic 55 Angiotensin Converting Enzyme 55 KRAS mutant 55 Uricase PEG 55 PDE4 inhibitor 55 Ilaris 55 cisplatin carboplatin 55 mitoxantrone plus 55 Zenapax 55 Sensipar R 55 hepatocellular cancer 55 Vitaxin 55 HuMax TAC 55 treatment naïve genotype 55 situ CIS 55 Natalizumab 55 advanced unresectable 55 Cx# [002] 55 YONDELIS R 55 IXEMPRA 55 ACAPODENE TM 55 Hycamtin 55 Acute Myeloid Leukaemia AML 55 ribavirin therapy 55 gastrointestinal stromal tumors GISTs 55 lintuzumab 55 hematological malignancy 55 selectively binds 55 Interferon gamma 55 chemotherapy cisplatin 55 Pegasys ® 55 Mantle Cell Lymphoma 55 alfa 2a 55 EndoTAG 55 antiangiogenic agent 55 PRT# 55 irinotecan containing 55 relapsing remitting multiple sclerosis 55 Novantrone 55 TACI Ig 55 CHOP cyclophosphamide doxorubicin vincristine 55 platelet inhibitor 55 Systemic lupus erythematosus SLE 55 severe oral mucositis 55 Sutent sunitinib 55 Aryplase 55 vemurafenib 55 Pertuzumab 55 PD LID 55 Pixantrone 55 Darinaparsin 55 Cytoxan ® 55 oral talactoferrin 55 SHPT 55 Tasimelteon 55 gastrointestinal stromal tumor 55 dacarbazine DTIC 55 voriconazole 55 IV melanoma 55 Prestara 55 SNT MC# 55 androgen receptor antagonist 55 certain NF kappa 55 Nucleoside 55 refractory systemic anaplastic 55 Myelodysplastic Syndrome MDS 55 NEUPOGEN 55 sorafenib Nexavar ® 55 mixed hyperlipidemia 55 T#I [002] 55 Intravenous CP 55 Civacir 55 teriflunomide 55 BN# [004] 55 TELCYTA 55 antimetabolite 55 interferon alfa 2b 55 tafamidis 55 somatostatin analogues 55 Ofatumumab 55 ISTODAX 55 OPAXIO 55 ZEVALIN 55 omacetaxine mepesuccinate 55 CXA 55 pancreatic insufficiency 55 Xyfid TM 55 tigecycline 55 ACTEMRA TM 55 ATryn ® 55 Erbitux cetuximab 55 Evoltra 55 poly ADP ribose polymerase 55 Factor VIIa 55 K ras mutations 55 metastatic carcinoid 55 otelixizumab 55 systemic juvenile idiopathic 55 primary hypercholesterolemia 55 low dose cytarabine 55 evaluating tivozanib 55 sitaxsentan 55 Taxotere ® 55 chlorambucil 55 mycophenolate mofetil 55 CAELYX 55 MabThera Rituxan 55 Oncaspar 55 lymphoma Hodgkin lymphoma 55 evaluating REVLIMID 55 AML acute myeloid 55 FASLODEX 55 azacitidine 55 bevacizumab Avastin 55 TNF alpha selectively neutralizing 55 CIMZIA ™ 55 Abiraterone acetate 55 epoprostenol sodium 55 PEG INTRON 55 LymphoStat B 55 lung pancreatic 55 EGFR expressing 55 perifosine 55 SinuNase ™ 55 RezularTM 55 huN# DM1 55 Rebif ® 55 Panzem R NCD 55 Bortezomib 55 RELOVAIR ™ 55 familial amyloidotic polyneuropathy FAP 55 veltuzumab 55 gastrointestinal stromal tumors GIST 55 assessing T DM1 55 follicular NHL 55 trastuzumab Herceptin R 55 riociguat 55 Niemann Pick type 55 Albuferon TM 55 OncoGel 55 dose escalation Phase 55 prostate cancer HRPC 55 CCR5 tropic HIV 55 Epirubicin 55 Behcet uveitis 55 Allovectin 7 R 55 Pegasys peginterferon alfa 2a 55 HER2 negative 55 ofatumumab 55 fluvastatin 55 autoantibody positive 55 demonstrated antitumor activity 55 refractory rituximab naive 55 relapsed SCLC 55 goserelin 55 adefovir dipivoxil 55 recurrent metastatic 55 gemcitabine chemotherapy 55 transcriptase inhibitor NNRTI 55 metastatic CRC 55 TTF Therapy 55 # Chartreuse et 55 polycythemia vera essential thrombocythemia 55 Elvitegravir 55 soft tissue sarcomas 55 Frova ® 54 Bayer Nexavar 54 iobenguane 54 Revlimid lenalidomide 54 T1c 54 peginterferon alfa 54 Eraxis 54 systemic lupus erythematosus SLE 54 non resectable 54 EGFR HER2 54 kidney urologic 54 systemic ALCL 54 steroid refractory ulcerative 54 Acute Myelogenous Leukemia AML 54 Janus kinase 54 nilotinib Tasigna ® 54 chronic immune thrombocytopenic 54 Vaprisol 54 diabetic neuropathic pain 54 Seliciclib 54 zanolimumab 54 Severe Primary IGFD 54 PKC# 54 investigational compound 54 Vivaglobin 54 tyrosine kinase inhibitor 54 chronic hepatitis B 54 dacetuzumab 54 elvucitabine 54 axitinib 54 haematologic 54 Chronic hepatitis B 54 follicular lymphoma FL 54 BRAF V# mutation 54 CAMPATH 54 Peginterferon Alfa 2a 54 phase Ib 54 TREDAPTIVE 54 anti CD3 monoclonal 54 Panzem NCD 54 Cimzia TM 54 Folfox 54 dose methotrexate 54 SUPPRELIN R LA 54 docetaxel Injection Concentrate 54 complement inhibitor eculizumab 54 mycosis fungoides 54 density lipoprotein cholesterol HDL